• Home
  • Articles
  • COVID-19
  • News
    • Biotech News – Featured
    • Biotech News – India
    • BioMedical
    • BioBusiness
    • BioResearch
    • BioGadgets
  • Interviews
    • Interviews – Academia
    • Interviews – Industry
  • Issues
    • Biotech Express Issues – Access Page
  • Subscribe
  • Board
  • Advertise
Facebook Twitter Instagram
Trending
  • Editorial: What serious side effects reported after inoculation of Indian COVID-19 vaccines: Survey of AEFI reports
  • COVID-19 scientists are facing an avalanche of abuse, Science survey shows
  • Editorial: Plastic found in human blood – Call an urgency to switch to bioplastic
  • Guestorial: Demand for Nationalization of Healthcare Services in India
  • 19 Year Old Allegedly Dies Post Covishield Vaccination: Kerala High Court Seeks Centre’s Response On Parents’ Plea
  • Phablecare Raises ₹187 Cr In Funding
  • Pfizer Hired 1,800 Additional Employees In 2021 To Process Huge Increase In Vaccine Adverse Events
  • Experts write to PM against WTO proposal on COVID-19 vaccine waivers
Biotech Express Magazine
  • Home
  • Articles
  • COVID-19
  • News
    • Biotech News – Featured
    • Biotech News – India
    • BioMedical
    • BioBusiness
    • BioResearch
    • BioGadgets
  • Interviews
    1. Interviews – Academia
    2. Interviews – Industry
    Featured
    January 16, 20211

    Interview – Prof Rajeev K Varshney “The Youngest Indian Scientist (47)” who achieved an h-index of 100 recently

    Recent
    March 30, 2022

    Interview- Bioenergy: India’s Ministry of New and Renewable Energy started almost four decades ago…but did not catch up…, Professor Ashok Pandey

    January 24, 2022

    Interview: Prof Kailash Chander Bansal, Secretary, National Academy of Agricultural Sciences (NAAS), India

    January 23, 2022

    Interview – Dr Heera Lal: How an IAS officer using Biotech approaches to transform Indian villages into “Organic Villages”

  • Issues
    • Biotech Express Issues – Access Page
  • Subscribe
  • Board
  • Advertise
Biotech Express Magazine
You are at:Home»Articles- News Reports»Mahima Datla and BP Acharya to receive FABA 2022 special awards

Mahima Datla and BP Acharya to receive FABA 2022 special awards

0
By Biotech Express on February 22, 2022 Articles- News Reports, Biotech News - India

Mahima Datla, managing director of Biological E Limited from Hyderabad and B P Acharya, patron of Federation of Asian Biotech Association (FABA) have been conferred with Dr B S Bajaj Memorial FABA Special Award-2022 and FABA Lifetime Achievement Award, respectively for their immense contribution to the biotechnology sector in India. The FABA special awards will be conferred during the 19th edition of BioAsia, the largest annual global biotechnology and life sciences summit of Asia, organised by the Government of Telangana and FABA.

The 44-year-old Mahima has a Bachelor’s Degree in Business Administration Management from Webster University, London, has been with Biological E since 2001. Founded in 1948 by her grandfathers as Biological Products Pvt Ltd, the company started out by manufacturing Heparin, a drug to prevent blood clots.

Mahima Datla is named for the FABA award for introducing Corbevax vaccine, which is regarded as India’s indigenously developed Covid-19 vaccine. Corbevax is a protein subunit COVID-19 vaccine developed by Texas Children’s Hospital Center for Vaccine Development and Baylor College of Medicine in Houston, Texas and Dynavax technologies based in Emeryville California. It is licensed to Indian biopharmaceutical firm Biological E. Limited (BioE) for development and production.

According to experts, Corbevax is a recombinant vaccine, developed from the receptor binding domain (RBD) of the spike protein on the virus’s surface combined with Dynavax’s CpG 1018 adjuvant with alum, which helps the body build the immune response against the virus. The protein is produced by the yeast Pichia pastoris; the process is similar to that of existing Hepatitis B vaccines.

Prof. Reddanna, executive president, FABA while speaking at the announcement of the awards, said, “The Dr B S Bajaj Memorial Award is a distinction bestowed on the individual or organization most committed to the advancement of Life Sciences. The contributions made by Biological E under the abled leadership of Mahima Datla are conscientiously recognized and commended by the biotechnology fraternity. Their vaccine, Corbevax being scalable and affordable to the low-middle income countries, makes Biological E the most promising candidate for this award”.

B. P. Acharya (born 30 October 1960) is a senior officer of the 1983 batch Indian Administrative Service (IAS). On his retirement in 2020, he was Director General for MCR HRD Institute of Telangana and also Special Chief Secretary in General Administration Department for Telangana State.

The Indian Council of Medical Research (ICMR) in 2021 has appointed retired Telangana bureaucrat BP Acharya, as the advisor of the National Animal Resource Facility for Bio Medical Research (NARFBR) that is coming up over an area of 100 acres at the Genome valley near Shamirpet.

Acharya had served as the Special Chief Secretary in before retirement and also as the DG of MCRHRD Institute of Telangana. The ICMR said that this appointment is in recognition of Acharya’s efforts to create the world-class life sciences cluster in the Genome Valley and his contribution to the sector. The NARFBR project is being developed with an investment of Rs 300 crore and will cater to the pharma and biopharma/vaccine industry in the country in their pre-clinical animal trials.

As Secretary, Industries and Commerce, he was involved in creating Genome Valley on the outskirts of Hyderabad and many such industrial clusters.[6] After retirement, he was appointed as advisor to the Indian Council of Medical Research for their National Animal Resource Facility for Biomedical Research in Genome Valley.

Adding further Reddanna also hailed the services rendered by B P Acharya, who has been conferred with FABA Lifetime Achievement Award and said that Acharya has been serving as advisor to ICMR for the National Animal Resource Facility for Biomedical Research (NARFBR) ever since the time of his retirement from MHRD in 2020 and his coordinating efforts and initiatives taken up by him during the regime of government of Andhra Pradesh are commendable as it has helped develop the concrete base for the Genome Valley and Biotech Sector in Hyderabad.

It is also learnt that B P Acharya’s efforts have enabled the erstwhile Andhra Pradesh state achieve the ‘Bio State of the Year 2003’ Award, 19 years ago and from then onwards the Biotechnology sector in Hyderabad has grown to become the global vaccine manufacturing hub in India.

About FABA
Federation of Asian Biotech Associations (FABA), established in 2005, is a non-profit organization created to provide a global platform for the development of biotechnology across the globe, particularly in Asian countries.

The mission of FABA is to promote innovation and entrepreneurship in the biotech industry, academia, and healthcare sector. For more than 15 years, FABA has been fostering collaboration between academia, industry, and government, thus promoting investments in biotechnology and related fields. FABA promotes collaboration between academia and industries engaged in Biotechnology among the member countries in Asia.

Know more: https://biofaba.org.in

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
Biotech Express
  • Website
  • Facebook
  • Twitter
  • LinkedIn

ISSN: 2454-6968 | Biotech Express Magazine publishes articles in the field of biotechnology and allied sciences in a way that have never been presented earlier. It publishes Editorials, Guest Articles, Reports, Interviews, Current News of Govt. Academics and Business, Research Highlights and Notifications of Events, Jobs, Research Proposals in the field of Biotechnology, Biological Sciences, Life Sciences, Microbiology, Biochemistry, Neurosciences, Genetics, Medical Sciences, BioPharma etc.

Related Posts

FDA Clears Marketing of Genome-Edited Beef Cattle

IISc, India to set up public health centre with Rs105 cr funding from philanthropist

Drs Ella deserve Padma Award for their innovations and management in biotechnology: India’s pioneer recombinant biologist Prof Ramareddy Guntaka

Leave A Reply Cancel Reply

Current Issue – April 2022

                   VIEW SUBSCRIPTION PLANS

JOBS/NOTIFICATIONS

   

         CLICK HERE FOR RECENT NOTICES

Recent Posts
  • Editorial: What serious side effects reported after inoculation of Indian COVID-19 vaccines: Survey of AEFI reports April 25, 2022
  • COVID-19 scientists are facing an avalanche of abuse, Science survey shows April 24, 2022
  • Editorial: Plastic found in human blood – Call an urgency to switch to bioplastic April 24, 2022
  • Guestorial: Demand for Nationalization of Healthcare Services in India April 24, 2022
  • 19 Year Old Allegedly Dies Post Covishield Vaccination: Kerala High Court Seeks Centre’s Response On Parents’ Plea April 15, 2022
  • Phablecare Raises ₹187 Cr In Funding April 11, 2022
  • Pfizer Hired 1,800 Additional Employees In 2021 To Process Huge Increase In Vaccine Adverse Events April 9, 2022
  • Experts write to PM against WTO proposal on COVID-19 vaccine waivers April 8, 2022
  • Bose Institute Scientists earn retraction due to manipulation April 5, 2022
  • WHO suspends Covaxin supply to UN agencies April 4, 2022
  • Lockdowns, Not the Pandemic, Created Havoc April 1, 2022
  • WHO selects Biological E to transfer mRNA COVID vaccine tech April 1, 2022
  • Dr. Reddy’s Laboratories and MediCane Health Announce the Launch of Medical Cannabis Products in Germany April 1, 2022
  • New Zealand High Court ENDS Vaccine Mandate: “It’s a Gross Violation of Human Rights” April 1, 2022
  • S&T Ministry to support startup in medical implants March 31, 2022
  • FDA Clears Marketing of Genome-Edited Beef Cattle March 30, 2022
  • Interview- Bioenergy: India’s Ministry of New and Renewable Energy started almost four decades ago…but did not catch up…, Professor Ashok Pandey March 30, 2022
  • Undisclosed industry payments rampant in drug-trial papers in Australia March 29, 2022
  • Fraud Trial of Former Theranos Executive Ramesh’ Sunny’ Balwani Begins March 29, 2022
  • Substandard, fake medical products increased by almost 47% from 2020 to 2021 during pandemic: report March 29, 2022
  • Editorial: Biofuels in India – a perfect waste to wealth and net zero emission energy option March 29, 2022
  • Bharat Biotech and BIOFABRI partner to develop, manufacture and distribute novel TB vaccine March 28, 2022
  • Fibroheal raises debt funding from BIRAC March 28, 2022
  • Editorial – Energy, Renewable Energy and Bioenergy March 28, 2022
  • IISc, India to set up public health centre with Rs105 cr funding from philanthropist March 27, 2022
  • Tamil Nadu makes scientifically dubious claim on vaccines in the Supreme Court March 27, 2022
  • Guest Article: GENE EDITED-CRISPERED FLOWERS: Blooming with grace March 27, 2022
  • Dr. Anthony Fauci, Biden admin operated with missing data as CDC issued pandemic guidance, emails show March 25, 2022
  • Contents – February 2022 March 3, 2022
  • Drs Ella deserve Padma Award for their innovations and management in biotechnology: India’s pioneer recombinant biologist Prof Ramareddy Guntaka February 26, 2022
Archives
Categories
  • Articles
  • Articles- Editorials
  • Articles- Guestorials
  • Articles- News Reports
  • BioControversial
  • BioEvents
  • BioGadgets
  • BioPolicies
  • BioResearch – Academic
  • BioResearch – Industry
  • Biotech – Agriculture
  • Biotech – Healthcare
  • Biotech – Supplies
  • Biotech News – Featured
  • Biotech News – India
  • Biotech News – Industry
  • Contents
  • Interviews
  • Interviews – Academia
  • Interviews – Industry
  • SARS- CoV2 & COVID-19 Updates
  • startups
About Us

Biotech Express Magazine publishes articles in the field of biotechnology and allied sciences in a way that have never been presented earlier. It publishes Editorials, Guest Articles, Reports,  Interviews, Current News of Govt. Academics and Business, Research Highlights and Notifications of Events, Jobs, Research Proposals in the field of Biotechnology and allied sciences like Biological Sciences, Life Sciences, Microbiology, Biochemistry, Neurology, Genetics, Medical Sciences, BioPharma etc.

Call us: _91-9311986177

Email – biotechexpressindia@gmail.com

About Us

About Biotech Express

Advisory and Editorial Board

Contact Us

Policy and Guidelines

Submission policies

Peer review policy    

Copyright policy

 

Follow Us
  • Facebook
  • Twitter
We use cookies to help provide and enhance our service and tailor content and ads. By continuing you agree to the use of cookies. Copyright © 2013-2020 Biotech Express except certain content provided by third parties.

Type above and press Enter to search. Press Esc to cancel.